Hematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control trials. Leuk Res 2021 11;110:106714
Date
10/02/2021Pubmed ID
34598075DOI
10.1016/j.leukres.2021.106714Scopus ID
2-s2.0-85115920018Author List
Yarlagadda N, Gundarlapalli S, Sharma S, Suelzer E, Abid MB, Abdallah AO, Schinke C, Atrash S, Mohan MAuthor
Muhammad Bilal Abid MD Assistant Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
ADP-ribosyl Cyclase 1Antibodies, Monoclonal
Communicable Diseases
Hematologic Diseases
Humans
Multiple Myeloma
Prognosis
Randomized Controlled Trials as Topic
